Passage Bio, Inc. Common Stock
$4.77
Market Cap
$15.35M
Shares Outstanding
3.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 28, 2020
Round Lot
100
Locale
US
Day Open
$4.83
Day High
$4.84
Day Low
$4.70
Volume
9.8K
VWAP
$4.82
Prev Close
$4.86
Transactions
--
Acc. Volume
--
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Passage Bio, Inc. Common Stock (PASG) closed the 2026-09-15 session at $4.77, down 1.85% versus the previous close (-0.09). The stock opened at $4.83 and traded between $4.70 and $4.84 during that session. Session trading volume was 10K shares. The volume-weighted average price (VWAP) is $4.82.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Passage Bio, Inc. Common Stock has a market capitalization of $15.3 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. PASG is listed on the XNAS exchange. The company employs approximately 24 people. Passage Bio, Inc. Common Stock is headquartered in PHILADELPHIA, PA. The recorded listing date is 2020-02-28.
On this page you can find market PASG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.